Highly prevalent in PCa cells and circulating tumor cells (CTCs), Ezrin serves as a valuable biomarker for tumor metastasis and prognostication (Z. Chen et al., 2022; Valdman et al., 2005). Here, EZR is linked to posterior cortical atrophy.